Rupashree Sen

Research Associate

20072019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Rupashree Sen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Apoptosis Medicine & Life Sciences
Leishmania donovani Medicine & Life Sciences
Inhibitory Concentration 50 Medicine & Life Sciences
Piper betle Medicine & Life Sciences
Caspases Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
U937 Cells Medicine & Life Sciences
Reactive Oxygen Species Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2007 2019

Mouse PVRIg has CD8+ T cell-specific coinhibitory functions and dampens antitumor immunity

Murter, B., Pan, X., Ophir, E., Alteber, Z., Azulay, M., Sen, R., Levy, O., Dassa, L., Vaknin, I., Fridman-Kfir, T., Salomon, R., Ravet, A., Tam, A., Levin, D., Vaknin, Y., Tatirovsky, E., Machlenkin, A., Pardoll, A. M. & Ganguly, S., Feb 1 2019, In : Cancer immunology research. 7, 2, p. 244-256 13 p.

Research output: Contribution to journalArticle

Immunity
T-Lymphocytes
Proteins
Tumor Microenvironment
poliovirus receptor

A novel epigenetic modulating agent sensitizes pancreatic cells to a chemotherapy agent

Thakar, M., Hu, Y., Morreale, M., Lerner, L., Lin, W. Y., Sen, R., Cai, Y., Karunasena, E., Thakar, M., Saggi, S., Keer, H. & Ahuja, N., Jun 1 2018, In : PLoS One. 13, 6, e0199130.

Research output: Contribution to journalArticle

Chemotherapy
adenocarcinoma
Epigenomics
epigenetics
drug therapy

Biodegradable STING agonist nanoparticles for enhanced cancer immunotherapy

Wilson, D. R., Sen, R., Sunshine, J. C., Pardoll, A. M., Green, J. & Kim, Y. J., Feb 1 2018, In : Nanomedicine: Nanotechnology, Biology, and Medicine. 14, 2, p. 237-246 10 p.

Research output: Contribution to journalArticle

Immunotherapy
Nanoparticles
Interferons
Tumors
Neoplasms

Treatment with epigenetic agents profoundly inhibits tumor growth in leiomyosarcoma

Fischer, C. D. C., Hu, Y., Morreale, M., Lin, W. Y., Wali, A., Thakar, M., Karunasena, E., Sen, R., Cai, Y., Murphy, L., Zahnow, C., Keer, H., Thakar, M. & Ahuja, N., Apr 10 2018, In : Oncotarget. 9, 27, p. 19379-19395 17 p.

Research output: Contribution to journalArticle

Leiomyosarcoma
Epigenomics
Azacitidine
Growth
Neoplasms

Autologous reconstitution of human cancer and immune system in vivo

Fu, J., Sen, R., Masica, D. L., Karchin, R., Pardoll, A. M., Walter, V., Hayes, D. N., Chung, C. H. & Kim, Y. J., 2017, In : Oncotarget. 8, 2, p. 2053-2068 16 p.

Research output: Contribution to journalArticle

Immune System
Tumor Microenvironment
Neoplasms
Human Trafficking
Tumor-Infiltrating Lymphocytes